Low frequency of ErbB-2 proto-oncogene overexpression in human leukocyte antigen-A2-positive breast cancer patients.
Nisticò
P
P
Laboratorio di Immunologia, CRS Istituto Tumori Regina Elena, Italy.
Mottolese
M
M
Mammi
C
C
Benevolo
M
M
Del Bello
D
D
Rubiu
O
O
Gentile
F P
FP
Botti
C
C
Venturo
I
I
Natali
P G
PG
D000368:Aged; D001943:Breast Neoplasms / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D002277:Carcinoma / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D018734:Genes, erbB-2; D015789:HLA-A2 Antigen; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D010641:Phenotype; D000090063:Proto-Oncogene Mas; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis*; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D015854:Up-Regulation
D015789:HLA-A2 Antigen; D000090063:Proto-Oncogene Mas; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C000715470:MAS1 protein, human